Comment on: Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)

Filippo Pinto e Vairo; Matthew J. Koster; Jennifer L. Kemppainen; Brittany C. Thomas; Kenneth J. Warrington

doi:10.1093/rheumatology/keab081

Comment on: Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)

Filippo Pinto e Vairo, Matthew J. Koster, Jennifer L. Kemppainen, Brittany C. Thomas, Kenneth J. Warrington

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	E218-E219
Journal	Rheumatology (United Kingdom)
Volume	60
Issue number	6
DOIs	https://doi.org/10.1093/rheumatology/keab081
State	Published - Jun 1 2021

ASJC Scopus subject areas

Rheumatology
Pharmacology (medical)

Access to Document

10.1093/rheumatology/keab081

Cite this

Comment on: Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2). / Pinto e Vairo, Filippo ; Koster, Matthew J.; Kemppainen, Jennifer L. et al.
In: Rheumatology (United Kingdom), Vol. 60, No. 6, 01.06.2021, p. E218-E219.

Research output: Contribution to journal › Letter › peer-review

@article{66f21652bc7f4caf88173539d656b40b,

title = "Comment on: Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)",

author = "{Pinto e Vairo}, Filippo and Koster, {Matthew J.} and Kemppainen, {Jennifer L.} and Thomas, {Brittany C.} and Warrington, {Kenneth J.}",

year = "2021",

month = jun,

day = "1",

doi = "10.1093/rheumatology/keab081",

language = "English (US)",

volume = "60",

pages = "E218--E219",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Comment on

T2 - Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)

AU - Pinto e Vairo, Filippo

AU - Koster, Matthew J.

AU - Kemppainen, Jennifer L.

AU - Thomas, Brittany C.

AU - Warrington, Kenneth J.

PY - 2021/6/1

Y1 - 2021/6/1

UR - http://www.scopus.com/inward/record.url?scp=85108742270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108742270&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/keab081

DO - 10.1093/rheumatology/keab081

M3 - Letter

C2 - 33515254

AN - SCOPUS:85108742270

SN - 1462-0324

VL - 60

SP - E218-E219

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 6

ER -

Comment on: Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this